Metabolism-Activated Multitargeting (MAMUT): An Innovative Multitargeting Approach to Drug Design and Development

P. Mátyus, Christina L L Chai

Research output: Contribution to journalArticle

4 Citations (Scopus)


Multitargeting is a valuable concept in drug design for the development of effective drugs for the treatment of multifactorial diseases. This concept has most frequently been realized by incorporating two or more pharmacophores into a single hybrid molecule. Many such hybrids, due to the increased molecular size, exhibit unfavorable physicochemical properties leading to adverse effects and/or an inappropriate ADME (absorption, distribution, metabolism, and excretion) profile. To avoid this limitation and achieve additional therapeutic benefits, here we describe a novel multitargeting strategy based on the synergistic effects of a parent drug and its active metabolite(s). The concept of metabolism-activated multitargeting (MAMUT) is illustrated using a number of examples.

Original languageEnglish
Pages (from-to)1197-1198
Number of pages2
Publication statusPublished - Jun 20 2016


  • active metabolites
  • designed multiple ligands (DMLs)
  • drug design
  • metabolism-activated multitargeting (MAMUT)
  • synergism

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Metabolism-Activated Multitargeting (MAMUT): An Innovative Multitargeting Approach to Drug Design and Development'. Together they form a unique fingerprint.

  • Cite this